VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
VolitionRx Limited (NYSE: VNRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants [Yahoo! Finance]
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants
VolitionRx Limited (NYSE: VNRX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.